Drug Discovery News spotlights Satellos Bioscience and its differentiated therapeutic approach for Duchenne muscular dystrophy (DMD). The article explores how Satellos is targeting the root cause of the disease—disrupted muscle stem cell repair—with a novel small molecule that aims to restore the body’s ability to regenerate muscle.
Read the article here.
